Dual-targeting organometallic ruthenium(ii) anticancer complexes bearing EGFR-inhibiting 4-anilinoquinazoline ligands
Keyword(s):
Organoruthenium complexes containing 4-anilinoquinazolines show dual-targeting activity, and highly inhibit the growth of the HeLa cancer cell line.